Article Sidebar

PDF (Tiếng Việt)
Published: 2022-11-29
Abstract Views: 385
Views PDF (Tiếng Việt): 370
DOI: https://doi.org/10.52852/tcncyh.v159i11.1292
Issue
Vol. 159 No. 11 (2022)
Section
Các bài báo
How to Cite
Thành, N. C. ., Lết, N. T. ., Tùng, N. Q., Tuấn, P. V., Huyền, Đỗ T. T., & Diệp, H. T. H. (2022). 23. Description of several hematological characteristics of patients with Anemia of chronic disease at Hanoi Medical University Hospital. Journal of Medical Research, 159(11), 187-194. https://doi.org/10.52852/tcncyh.v159i11.1292

23. Description of several hematological characteristics of patients with Anemia of chronic disease at Hanoi Medical University Hospital

Nguyen Chi Thanh, Nguyen Thi Let, Nguyen Quang Tung, Pham Van Tuan, Do Thi Thanh Huyen, Hoang Thi Hong Diep

Main Article Content

Abstract

This study describes results obtained from hematological test in patients with anemia due to chronic disease. The patients received treatment at Ha Noi Medical University from May 2020 to September 2021. The mean hemoglobin concentration of red blood cells and the mean hemoglobin concentration of ACD group without iron deficiency were significantly higher than that of ACD group with iron deficiency (p = 0.05). Patients with ACD mainly have mild anemia (67.2%), with moderate anemia accounted for 28.7% and severe anemia accounted for 4.1%. Anemia of normochromic red blood cells accounted for the highest percentage (62.3%); hypochromic microcytic anemia accounted for 34.4%; and severe anemia accounts for 3.3%.

Article Details

Keywords

Anemia of chronic disease, hematological test, Ha Noi Medical University.

References

1. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019; 133(1): 40-50. doi:10.1182/blood-2018-06-856500.
2. Steinbicker A, Muckenthaler M. Out of Balance-Systemic Iron Homeostasis in Iron-Related Disorders. Nutrients. 2013; 5(8): 3034-3061. doi:10.3390/nu5083034.
3. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004; 20(9): 1501-1510. doi:10.1185/030079904X2763.
4. Chen Y fan, Xu S qian, Xu Y chen, et al. Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis. Clin Rheumatol. Published online January 9, 2020. doi:10.1007/s10067-019-04873-y.
5. Zian Z, Maamar M, Aouni ME, et al. Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco. BioMed Research International. 2018; 2018: 1-5. doi:10.1155/2018/3139404.
6. Mirza FG, Abdul-Kadir R, Breymann C, Fraser IS, Taher A. Impact and management of iron deficiency and iron deficiency anemia in women’s health. Expert Review of Hematology. 2018; 11(9): 727-736. doi:10.1080/17474086.2018.1502081.
7. Weiss G. Anemia of Chronic Disease. The New England Journal of Medicine. Published online 2005:13.
8. Cullis JO. Diagnosis and management of anaemia of chronic disease: current status: Review. British Journal of Haematology. 2011; 154(3): 289-300. doi:10.1111/j.1365-2141.2011.08741.x.
9. Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol. 2003; 25(6): 353-357. doi:10.1046/j.0141-9854.2003.00548.x.
10. Schop A, Stouten K, van Houten R, et al. Diagnostics in anaemia of chronic disease in general practice: a real-world retrospective cohort study. BJGP Open. 2018; 2(3): bjgpopen18X101597. doi:10.3399/bjgpopen18X101597.
11. Kurz K, Lanser L, Seifert M, Kocher F, Pölzl G, Weiss G. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Failure. 2020; 7(4): 1880-1890. doi:10.1002/ehf2.12755.
12. H MKM, Nipanal AV, L AM. Utility of sTFR/Ferritin index to differentiate iron deficiency anaemia and anaemia of chronic disease. IP Journal of Nutrition, Metabolism and Health Science. 2021; 3(4): 119-123. doi:10.18231/j.ijnmhs.2020.024.
13. Weiss G. Iron metabolism in the anemia of chronic disease. Biochimica et Biophysica Acta (BBA) - General Subjects. 2009; 1790(7): 682-693. doi:10.1016/j.bbagen.2008.08.006.
14. Marković M, Majkić-Singh N, Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scandinavian Journal of Clinical and Laboratory Investigation. 2005; 65(7): 571-576. doi:10.1080/00365510500206542.
15. Chua E, Clague JE, Sharma AK, Horan MA, Lombard M. Serum transferrin receptor assay in iron deficiency anaemia and anaemia of chronic disease in the elderly. QJM: An International Journal of Medicine. 1999; 92(10): 587-594. doi:10.1093/qjmed/92.10.587.
16. Khalaf W, Al-Rubaie HA, Shihab S. Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin. Hematol Rep. 2019; 11(1). doi:10.4081/hr.2019.7708.
17. Jain S, Narayan S, Chandra J, Sharma S, Jain S, Malhan P. Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease. Indian J Pediatr. 2010; 77(2): 179-183. doi:10.1007/s12098-009-0302-z.
18. Wiciński M, Liczner G, Cadelski K, Kołnierzak T, Nowaczewska M, Malinowski B. Anemia of Chronic Diseases: Wider Diagnostics-Better Treatment? Nutrients. 2020; 12(6): 1784. doi:10.3390/nu12061784.
19. Madu AJ, Ughasoro MD. Anaemia of Chronic Disease: An In-Depth Review. Med Princ Pract. 2017; 26(1): 1-9. doi:10.1159/000452104.